Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hematology
Pharma
JPM24: Roche touts its rebound in hematology, led by Hemlibra
After a period of declining sales in hematology, Roche is rebounding quickly with blockbuster Hemlibra and new bispecifics Lunsumio and Columvi.
Kevin Dunleavy
Jan 9, 2024 4:26pm
In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo
May 10, 2023 11:25am
Argenx builds clinical case for 'pipeline in a product' efgart
Dec 10, 2022 11:30am
Takeda, BMS-BeiGene, Samsung and more—Fierce Pharma Asia
Oct 15, 2021 9:00am
Pick the Commish: Fierce Pharma voters select Abernethy
Dec 21, 2020 11:36am
Bristol Myers Squibb hematology chief talks COVID-19 challenges
Oct 12, 2020 10:35am
